A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine

COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Kana, Mashiba, Takahisa, Takano, Keisuke, Suzuki, Toshihiko, Kami, Masahiro, Takita, Morihito, Kusumi, Eiji, Mizuno, Yasuhiro, Hamaki, Tamae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538620/
https://www.ncbi.nlm.nih.gov/pubmed/34696214
http://dx.doi.org/10.3390/vaccines9101108
Descripción
Sumario:COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first dose of COVID-19 vaccination. This case report shows the importance of considering hyperthyroidism as a possible complication after COVID-19 vaccination.

Ejemplares similares